Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Remission in psoriatic arthritis-where are we now?

Identifieur interne : 000449 ( PubMed/Checkpoint ); précédent : 000448; suivant : 000450

Remission in psoriatic arthritis-where are we now?

Auteurs : Laura C. Coates [Royaume-Uni] ; Philip G. Conaghan [Royaume-Uni] ; Maria Antonietta D'Agostino ; Maarten De Wit [Pays-Bas] ; Oliver Fitzgerald [Irlande (pays)] ; Tore K. Kvien [Norvège] ; Rik Lories [Belgique] ; Philip Mease ; Peter Nash [Australie] ; Georg Schett [Allemagne] ; Enrique R. Soriano [Argentine] ; Paul Emery [Royaume-Uni]

Source :

RBID : pubmed:29045698

Abstract

Advances in treatments and treatment strategies for PsA have led to many patients responding well to management of their disease, and targeting remission as a treatment goal is now a possibility. Treat to target is a strategy aimed at maximizing benefit, irrespective of the type of medication used, by monitoring disease activity and using it to guide therapy. The measurement of response to treatment has been the subject of wide discussions among experts for some time, and many instruments exist. Comparisons of the different measures and their different strengths and weaknesses is ongoing. The impact of modern imaging techniques on monitoring disease progression is also evolving, and advanced techniques using both MRI and US have the potential to improve management of PsA through identification of risk factors for poor prognosis as well as accurate assessment of inflammation and damage, including subclinical disease. Increased understanding of the pathways that drive the pathogenesis of PsA will be key to identifying specific biomarkers for the disease and developing effective treatment strategies. Targets for response, considerations for use of a treat to target strategy in PsA, different imaging techniques and serological aspects of remission are all discussed in this review, and areas for further research are identified.

DOI: 10.1093/rheumatology/kex344
PubMed: 29045698


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:29045698

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Remission in psoriatic arthritis-where are we now?</title>
<author>
<name sortKey="Coates, Laura C" sort="Coates, Laura C" uniqKey="Coates L" first="Laura C" last="Coates">Laura C. Coates</name>
<affiliation wicri:level="4">
<nlm:affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds</wicri:regionArea>
<orgName type="university">Université de Leeds</orgName>
<placeName>
<settlement type="city">Leeds</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Yorkshire-et-Humber</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Conaghan, Philip G" sort="Conaghan, Philip G" uniqKey="Conaghan P" first="Philip G" last="Conaghan">Philip G. Conaghan</name>
<affiliation wicri:level="4">
<nlm:affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds</wicri:regionArea>
<orgName type="university">Université de Leeds</orgName>
<placeName>
<settlement type="city">Leeds</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Yorkshire-et-Humber</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="D Agostino, Maria Antonietta" sort="D Agostino, Maria Antonietta" uniqKey="D Agostino M" first="Maria Antonietta" last="D'Agostino">Maria Antonietta D'Agostino</name>
<affiliation>
<nlm:affiliation>APHP, Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt, 92100.</nlm:affiliation>
<wicri:noCountry code="subField">92100</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="De Wit, Maarten" sort="De Wit, Maarten" uniqKey="De Wit M" first="Maarten" last="De Wit">Maarten De Wit</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Medical Humanities, VU University Medical Centre, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Medical Humanities, VU University Medical Centre, Amsterdam</wicri:regionArea>
<placeName>
<settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fitzgerald, Oliver" sort="Fitzgerald, Oliver" uniqKey="Fitzgerald O" first="Oliver" last="Fitzgerald">Oliver Fitzgerald</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Rheumatology, St Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>Department of Rheumatology, St Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin</wicri:regionArea>
<wicri:noRegion>University College Dublin</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kvien, Tore K" sort="Kvien, Tore K" uniqKey="Kvien T" first="Tore K" last="Kvien">Tore K. Kvien</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Rheumatology, Diakonhjemmet Hospital, Oslo</wicri:regionArea>
<placeName>
<settlement type="city">Oslo</settlement>
<region nuts="2">Østlandet</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lories, Rik" sort="Lories, Rik" uniqKey="Lories R" first="Rik" last="Lories">Rik Lories</name>
<affiliation wicri:level="1">
<nlm:affiliation>Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium; Division of Rheumatology, UZ Leuven, Leuven, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium; Division of Rheumatology, UZ Leuven, Leuven</wicri:regionArea>
<wicri:noRegion>Leuven</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mease, Philip" sort="Mease, Philip" uniqKey="Mease P" first="Philip" last="Mease">Philip Mease</name>
<affiliation>
<nlm:affiliation>University of Washington School of Medicine.</nlm:affiliation>
<wicri:noCountry code="no comma">University of Washington School of Medicine.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Nash, Peter" sort="Nash, Peter" uniqKey="Nash P" first="Peter" last="Nash">Peter Nash</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, University of Queensland, Brisbane, Queensland, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Queensland, Brisbane, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schett, Georg" sort="Schett, Georg" uniqKey="Schett G" first="Georg" last="Schett">Georg Schett</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Internal Medicine 3 and Institute for Clinical Immunology, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Internal Medicine 3 and Institute for Clinical Immunology, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen</wicri:regionArea>
<placeName>
<settlement type="city">Erlangen</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Moyenne-Franconie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Soriano, Enrique R" sort="Soriano, Enrique R" uniqKey="Soriano E" first="Enrique R" last="Soriano">Enrique R. Soriano</name>
<affiliation wicri:level="1">
<nlm:affiliation>Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation>
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires</wicri:regionArea>
<wicri:noRegion>Buenos Aires</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Emery, Paul" sort="Emery, Paul" uniqKey="Emery P" first="Paul" last="Emery">Paul Emery</name>
<affiliation wicri:level="4">
<nlm:affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds</wicri:regionArea>
<orgName type="university">Université de Leeds</orgName>
<placeName>
<settlement type="city">Leeds</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Yorkshire-et-Humber</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:29045698</idno>
<idno type="pmid">29045698</idno>
<idno type="doi">10.1093/rheumatology/kex344</idno>
<idno type="wicri:Area/PubMed/Corpus">000256</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000256</idno>
<idno type="wicri:Area/PubMed/Curation">000254</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000254</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000254</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000254</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Remission in psoriatic arthritis-where are we now?</title>
<author>
<name sortKey="Coates, Laura C" sort="Coates, Laura C" uniqKey="Coates L" first="Laura C" last="Coates">Laura C. Coates</name>
<affiliation wicri:level="4">
<nlm:affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds</wicri:regionArea>
<orgName type="university">Université de Leeds</orgName>
<placeName>
<settlement type="city">Leeds</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Yorkshire-et-Humber</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Conaghan, Philip G" sort="Conaghan, Philip G" uniqKey="Conaghan P" first="Philip G" last="Conaghan">Philip G. Conaghan</name>
<affiliation wicri:level="4">
<nlm:affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds</wicri:regionArea>
<orgName type="university">Université de Leeds</orgName>
<placeName>
<settlement type="city">Leeds</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Yorkshire-et-Humber</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="D Agostino, Maria Antonietta" sort="D Agostino, Maria Antonietta" uniqKey="D Agostino M" first="Maria Antonietta" last="D'Agostino">Maria Antonietta D'Agostino</name>
<affiliation>
<nlm:affiliation>APHP, Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt, 92100.</nlm:affiliation>
<wicri:noCountry code="subField">92100</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="De Wit, Maarten" sort="De Wit, Maarten" uniqKey="De Wit M" first="Maarten" last="De Wit">Maarten De Wit</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Medical Humanities, VU University Medical Centre, Amsterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Medical Humanities, VU University Medical Centre, Amsterdam</wicri:regionArea>
<placeName>
<settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fitzgerald, Oliver" sort="Fitzgerald, Oliver" uniqKey="Fitzgerald O" first="Oliver" last="Fitzgerald">Oliver Fitzgerald</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Rheumatology, St Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>Department of Rheumatology, St Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin</wicri:regionArea>
<wicri:noRegion>University College Dublin</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kvien, Tore K" sort="Kvien, Tore K" uniqKey="Kvien T" first="Tore K" last="Kvien">Tore K. Kvien</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.</nlm:affiliation>
<country xml:lang="fr">Norvège</country>
<wicri:regionArea>Department of Rheumatology, Diakonhjemmet Hospital, Oslo</wicri:regionArea>
<placeName>
<settlement type="city">Oslo</settlement>
<region nuts="2">Østlandet</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lories, Rik" sort="Lories, Rik" uniqKey="Lories R" first="Rik" last="Lories">Rik Lories</name>
<affiliation wicri:level="1">
<nlm:affiliation>Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium; Division of Rheumatology, UZ Leuven, Leuven, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium; Division of Rheumatology, UZ Leuven, Leuven</wicri:regionArea>
<wicri:noRegion>Leuven</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mease, Philip" sort="Mease, Philip" uniqKey="Mease P" first="Philip" last="Mease">Philip Mease</name>
<affiliation>
<nlm:affiliation>University of Washington School of Medicine.</nlm:affiliation>
<wicri:noCountry code="no comma">University of Washington School of Medicine.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Nash, Peter" sort="Nash, Peter" uniqKey="Nash P" first="Peter" last="Nash">Peter Nash</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medicine, University of Queensland, Brisbane, Queensland, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, University of Queensland, Brisbane, Queensland</wicri:regionArea>
<wicri:noRegion>Queensland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schett, Georg" sort="Schett, Georg" uniqKey="Schett G" first="Georg" last="Schett">Georg Schett</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Internal Medicine 3 and Institute for Clinical Immunology, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Internal Medicine 3 and Institute for Clinical Immunology, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen</wicri:regionArea>
<placeName>
<settlement type="city">Erlangen</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Moyenne-Franconie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Soriano, Enrique R" sort="Soriano, Enrique R" uniqKey="Soriano E" first="Enrique R" last="Soriano">Enrique R. Soriano</name>
<affiliation wicri:level="1">
<nlm:affiliation>Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation>
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires</wicri:regionArea>
<wicri:noRegion>Buenos Aires</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Emery, Paul" sort="Emery, Paul" uniqKey="Emery P" first="Paul" last="Emery">Paul Emery</name>
<affiliation wicri:level="4">
<nlm:affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds</wicri:regionArea>
<orgName type="university">Université de Leeds</orgName>
<placeName>
<settlement type="city">Leeds</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Yorkshire-et-Humber</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Rheumatology (Oxford, England)</title>
<idno type="eISSN">1462-0332</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Advances in treatments and treatment strategies for PsA have led to many patients responding well to management of their disease, and targeting remission as a treatment goal is now a possibility. Treat to target is a strategy aimed at maximizing benefit, irrespective of the type of medication used, by monitoring disease activity and using it to guide therapy. The measurement of response to treatment has been the subject of wide discussions among experts for some time, and many instruments exist. Comparisons of the different measures and their different strengths and weaknesses is ongoing. The impact of modern imaging techniques on monitoring disease progression is also evolving, and advanced techniques using both MRI and US have the potential to improve management of PsA through identification of risk factors for poor prognosis as well as accurate assessment of inflammation and damage, including subclinical disease. Increased understanding of the pathways that drive the pathogenesis of PsA will be key to identifying specific biomarkers for the disease and developing effective treatment strategies. Targets for response, considerations for use of a treat to target strategy in PsA, different imaging techniques and serological aspects of remission are all discussed in this review, and areas for further research are identified.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">29045698</PMID>
<DateCreated>
<Year>2017</Year>
<Month>10</Month>
<Day>18</Day>
</DateCreated>
<DateRevised>
<Year>2017</Year>
<Month>10</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1462-0332</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2017</Year>
<Month>Oct</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>Rheumatology (Oxford, England)</Title>
<ISOAbbreviation>Rheumatology (Oxford)</ISOAbbreviation>
</Journal>
<ArticleTitle>Remission in psoriatic arthritis-where are we now?</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/rheumatology/kex344</ELocationID>
<Abstract>
<AbstractText>Advances in treatments and treatment strategies for PsA have led to many patients responding well to management of their disease, and targeting remission as a treatment goal is now a possibility. Treat to target is a strategy aimed at maximizing benefit, irrespective of the type of medication used, by monitoring disease activity and using it to guide therapy. The measurement of response to treatment has been the subject of wide discussions among experts for some time, and many instruments exist. Comparisons of the different measures and their different strengths and weaknesses is ongoing. The impact of modern imaging techniques on monitoring disease progression is also evolving, and advanced techniques using both MRI and US have the potential to improve management of PsA through identification of risk factors for poor prognosis as well as accurate assessment of inflammation and damage, including subclinical disease. Increased understanding of the pathways that drive the pathogenesis of PsA will be key to identifying specific biomarkers for the disease and developing effective treatment strategies. Targets for response, considerations for use of a treat to target strategy in PsA, different imaging techniques and serological aspects of remission are all discussed in this review, and areas for further research are identified.</AbstractText>
<CopyrightInformation>© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Coates</LastName>
<ForeName>Laura C</ForeName>
<Initials>LC</Initials>
<AffiliationInfo>
<Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Conaghan</LastName>
<ForeName>Philip G</ForeName>
<Initials>PG</Initials>
<AffiliationInfo>
<Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>D'Agostino</LastName>
<ForeName>Maria Antonietta</ForeName>
<Initials>MA</Initials>
<AffiliationInfo>
<Affiliation>APHP, Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt, 92100.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, Saint-Quentin en Yvelines, 78180, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Wit</LastName>
<ForeName>Maarten</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Humanities, VU University Medical Centre, Amsterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>FitzGerald</LastName>
<ForeName>Oliver</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology, St Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin, Ireland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kvien</LastName>
<ForeName>Tore K</ForeName>
<Initials>TK</Initials>
<AffiliationInfo>
<Affiliation>Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lories</LastName>
<ForeName>Rik</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium; Division of Rheumatology, UZ Leuven, Leuven, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mease</LastName>
<ForeName>Philip</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>University of Washington School of Medicine.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Clinical Research Division, Swedish Medical Center, Seattle, WA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nash</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, University of Queensland, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schett</LastName>
<ForeName>Georg</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine 3 and Institute for Clinical Immunology, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Soriano</LastName>
<ForeName>Enrique R</ForeName>
<Initials>ER</Initials>
<AffiliationInfo>
<Affiliation>Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Emery</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>10</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Rheumatology (Oxford)</MedlineTA>
<NlmUniqueID>100883501</NlmUniqueID>
<ISSNLinking>1462-0324</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Doppler ultrasound</Keyword>
<Keyword MajorTopicYN="N">MRI</Keyword>
<Keyword MajorTopicYN="N">PsA</Keyword>
<Keyword MajorTopicYN="N">biomarkers</Keyword>
<Keyword MajorTopicYN="N">disease activity</Keyword>
<Keyword MajorTopicYN="N">imaging</Keyword>
<Keyword MajorTopicYN="N">remission</Keyword>
<Keyword MajorTopicYN="N">tight control</Keyword>
<Keyword MajorTopicYN="N">treat to target</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>02</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>10</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>10</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>10</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29045698</ArticleId>
<ArticleId IdType="pii">4554480</ArticleId>
<ArticleId IdType="doi">10.1093/rheumatology/kex344</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Argentine</li>
<li>Australie</li>
<li>Belgique</li>
<li>Irlande (pays)</li>
<li>Norvège</li>
<li>Pays-Bas</li>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Bavière</li>
<li>District de Moyenne-Franconie</li>
<li>Hollande-Septentrionale</li>
<li>Yorkshire-et-Humber</li>
<li>Østlandet</li>
</region>
<settlement>
<li>Amsterdam</li>
<li>Erlangen</li>
<li>Leeds</li>
<li>Oslo</li>
</settlement>
<orgName>
<li>Université de Leeds</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="D Agostino, Maria Antonietta" sort="D Agostino, Maria Antonietta" uniqKey="D Agostino M" first="Maria Antonietta" last="D'Agostino">Maria Antonietta D'Agostino</name>
<name sortKey="Mease, Philip" sort="Mease, Philip" uniqKey="Mease P" first="Philip" last="Mease">Philip Mease</name>
</noCountry>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Coates, Laura C" sort="Coates, Laura C" uniqKey="Coates L" first="Laura C" last="Coates">Laura C. Coates</name>
</region>
<name sortKey="Conaghan, Philip G" sort="Conaghan, Philip G" uniqKey="Conaghan P" first="Philip G" last="Conaghan">Philip G. Conaghan</name>
<name sortKey="Emery, Paul" sort="Emery, Paul" uniqKey="Emery P" first="Paul" last="Emery">Paul Emery</name>
</country>
<country name="Pays-Bas">
<region name="Hollande-Septentrionale">
<name sortKey="De Wit, Maarten" sort="De Wit, Maarten" uniqKey="De Wit M" first="Maarten" last="De Wit">Maarten De Wit</name>
</region>
</country>
<country name="Irlande (pays)">
<noRegion>
<name sortKey="Fitzgerald, Oliver" sort="Fitzgerald, Oliver" uniqKey="Fitzgerald O" first="Oliver" last="Fitzgerald">Oliver Fitzgerald</name>
</noRegion>
</country>
<country name="Norvège">
<region name="Østlandet">
<name sortKey="Kvien, Tore K" sort="Kvien, Tore K" uniqKey="Kvien T" first="Tore K" last="Kvien">Tore K. Kvien</name>
</region>
</country>
<country name="Belgique">
<noRegion>
<name sortKey="Lories, Rik" sort="Lories, Rik" uniqKey="Lories R" first="Rik" last="Lories">Rik Lories</name>
</noRegion>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Nash, Peter" sort="Nash, Peter" uniqKey="Nash P" first="Peter" last="Nash">Peter Nash</name>
</noRegion>
</country>
<country name="Allemagne">
<region name="Bavière">
<name sortKey="Schett, Georg" sort="Schett, Georg" uniqKey="Schett G" first="Georg" last="Schett">Georg Schett</name>
</region>
</country>
<country name="Argentine">
<noRegion>
<name sortKey="Soriano, Enrique R" sort="Soriano, Enrique R" uniqKey="Soriano E" first="Enrique R" last="Soriano">Enrique R. Soriano</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000449 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000449 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:29045698
   |texte=   Remission in psoriatic arthritis-where are we now?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:29045698" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024